Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IHJ-301
- Development stage
- Preclinical
- Lead developer
- iHeart Japan
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Hydrogel Systems → Drug Delivery Systems
- Administration
- Epicardial
01
Overview
IHJ-301 is an induced pluripotent stem cell (iPSC)-derived regenerative medicine product developed by iHeart Japan for the treatment of severe heart failure, including dilated cardiomyopathy and ischemic heart disease. The therapy consists of multi-layered cardiovascular cell sheets manufactured using a proprietary gelatin hydrogel microsphere technology originally developed at Kyoto University. IHJ-301 functions primarily through a paracrine mechanism, where the transplanted cells secrete a variety of cytokines and extracellular vesicles that promote tissue repair and improve cardiac function. Preclinical studies in porcine myocardial infarction models have demonstrated significant recovery of cardiac function, with levels reaching those of healthy subjects.
- Other names
- cardiovascular cell multilayer productmulti-layered cardiac cell sheets再生医療製品
Beyond the preview
Go deeper on IHJ-301.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IHJ-301.